Navigation Links
Hanger Orthopedic Group, Inc. Announces Three Acquisitions Totaling $10.7 Million of Annual Net Revenue
Date:10/8/2009

BETHESDA, Md., Oct. 8 /PRNewswire-FirstCall/ -- Hanger Orthopedic Group, Inc. (NYSE: HGR) is pleased to announce that it recently acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania. These acquisitions add patient care centers to existing markets in New York, Wyoming and Pennsylvania.

President and CEO, Thomas F. Kirk stated, "We are extremely pleased to welcome the talented professionals to the Hanger team. They bring outstanding patient care centers in their respective markets and will add value to our core O&P business. As with our previous transactions, they were financed with internally generated cash flows and will be accretive to earnings after completion of the initial integration period."

Hanger Orthopedic Group, Inc., headquartered in Bethesda, Maryland, is the world's premier provider of orthotic and prosthetic patient care services. Hanger is the market leader in the United States, owning and operating 671 patient care centers in 45 states and the District of Columbia, with over 3,700 employees including 1,090 practitioners (as of June 30, 2009). Hanger is organized into four units. The two key operating units are patient care, which consists of nationwide orthotic and prosthetic practice centers, and distribution which consists of distribution centers managing the supply chain of orthotic and prosthetic componentry to Hanger and third party patient care centers. The third is Linkia, which is the first and only provider network management company for the orthotics and prosthetics industry. The fourth unit, Innovative Neurotronics, introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers worldwide. For more
'/>"/>

SOURCE Hanger Orthopedic Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Wound Management Technologies Acquires Resorbable Orthopedics
2. Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma
3. First Human Implant of New Archus Orthopedics Facet Replacement System
4. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
5. Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro)
6. Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida
7. Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant
8. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
9. Stereotaxis Announces Public Offering of Common Stock
10. Lexicon Announces Pricing of Common Stock in Public Offering
11. Mirixa Corporation Announces Key Pharmacy Network Hire

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...N.J.,Nov.25/PRNewswire/--TheFDAgrantedtraditionala...nucleosidereversetranscriptaseinhibitor(NNRTI).INT...reatment-experiencedadultswhoareexperiencingvirolo...erantiretroviral(ARV)agents.Thetraditionalapproval...T-1andDUET-2.INTELENCEiscurrentlymarketedintheU.S....
(Date:11/25/2009)...Md.,Nov.25/PRNewswire-USNewswire/--RemediumTechnol...thatstopsseverebleeding,wonfirstprizeand$10,000int...rityChallenge2009,companyofficialsannouncetoday. ,...rld,Remedium,steampitchedtheirinventionattheGSCSec...ss. ,, Remedium( www.remediumtechnologies.com )...
(Date:11/25/2009)...,N.J.,Nov.25/PRNewswire/--RegadoBiosciences,apriva...icaptamerswithactivecontrolagents,announcedthatDav...iperJaffray21stAnnualHealthCareConferenceattheNewY...willbegivenat1:10pm(EST)onTuesday,December1andwill...sontheleaddevelopmentprogram,theanticoagulantsyste...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2MinuteClinic Offers New Rapid Pink Eye Test 3B Detects Viral Conjunctivitis Infections in Minutes 54196 1MinuteClinic Offers New Rapid Pink Eye Test 3B Detects Viral Conjunctivitis Infections in Minutes 54196 2MinuteClinic Offers New Rapid Pink Eye Test 3B Detects Viral Conjunctivitis Infections in Minutes 54196 3Foundation Radiology Group Signs Exclusive Contract With Uniontown Hospital 54193 1Foundation Radiology Group Signs Exclusive Contract With Uniontown Hospital 54193 2Photo 3A Stopain and the Arthritis Foundation Join Forces to Promote the Benefits of Staying Active 54192 1Photo 3A Stopain and the Arthritis Foundation Join Forces to Promote the Benefits of Staying Active 54192 2
...he Treatment of Inflammatory ...Payment from Partner GlaxoSmithKline, MOUNTAIN VI...unced the initiation of a Phase I clinical trial o...e compound designed to specifically,target the CCR...ammatory,diseases such as rheumatoid arthritis. Wi...
...i Corporation (,Iomai,) in a, fully recommended sh...ai,s common stock representing a fully diluted e...llion (EUR 122 million). Acquisition to be, accomp...imately 41 percent of Iomai,s current shares outs...ly 1.7 million Intercell shares (representing appr...
Other Medicine Technology:ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 2ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 3ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 4ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 3Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 4Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 6Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 7Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 8Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 9Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 10Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 11
(Date:11/26/2009)...ers from the North Pole, Textsanta.net lets parent...a , North Pole, AK (PRWEB...cies at the North Pole Santa Claus has added SMS t...lobe informed of his Christmas progress at the Nor...tment have identified a large and growing percenta...
(Date:11/25/2009)...USNewswire/--WhenmostpeopleheartheacronymTMJ,theyt...entsthehelptheyneed.TMJstandsfortheTemporal-Mandib...nnectswithyourskull(temporalbone). ,, Themostco...hchewing,clickingorpoppingofthejaw.Butmanyothersym...hes,fatigue,sleepdisturbances,irritability,alossin...
(Date:11/25/2009)...wire/--Thanksgivingmealswillbedeliveredtoapproxima...thankstoFaithInAction/VolunteerActionforAging,apro...CANHealthPlan.Formorethan17yearstheseorganizations...sgivingmealstoseniorsinneedinLongBeach,Lakewood,Si...ies. ,, "Ourwarmholidaymealsaredeliveredtopeopl...
(Date:11/25/2009)...ncer who were treated with cisplatin-based chemoth...ological side effects and Raynaud-like phenomena, ...ccording to a new study published online November ...e . , Marianne Brydy, M.D., of the Department of...n, Norway, and colleagues conducted a cross-sectio...
(Date:11/25/2009)...atoid arthritis, could help newly diagnosed diabet...(HealthDay News) -- A drug commonly used to treat ...w also shows some promise in helping patients newl...ituximab (Rituxan), helped patients keep producing...e had destroyed some of their pancreatic beta cell...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
... HCA announces the,following Webcast:, What: ... Where: http://www.videonewswire.com/event.as...Simply log on to the web at the address...s and operates approximately 169 hospitals and app...
...nc. (Nasdaq:,EVVV) today announced that Robert Pal...scheduled to present at the Bank of America 2008 H...:00 p.m. PT (7:00 p.m. ET and 6:00,p.m. CT). The B...ection of the ev3 Web site,at http://www.ev3.net ...
...00 doctors,have given 20 million free books to Ame... to Reach Out and Read. Partnering with doctors to...o their parents at check-ups, Reach,Out and Read n...(Photo: http://www.newscom.com/cgi-bin/prnh/20080...
...n Overnight Trip Than Having Own Toothbrush, PRIN...a relationship do men and women feel comfortable s...had to choose between not brushing,their teeth for...ppropriate alternative use for their old-fashioned...
...odborne diseases cause an estimated 76 million ill...iated with restaurant meals. More than 70 billion ... U.S., accounting for 47% of total food expenditur...in the June 2008 issue of the American Journal of ...
... an 89% initial success,rate in arresting or eradi...ville-based treatment is being offered to the publ...tion Director of Research Dr. Stephen,Cantrell, ga...t melanoma, as well as pancreatic and some of the ...
Other Medicine News:Health News:20 Million Kids' Books Distributed, 25% of U.S. Children in Poverty Getting Books, 50,000 Doctors Trained: Three Key Milestones for Reach Out and Read 2Health News:Crest(R) SPINBRUSH(R) Oral Hygiene Survey Reveals "Nothin' but the Tooth" 2Health News:Crest(R) SPINBRUSH(R) Oral Hygiene Survey Reveals "Nothin' but the Tooth" 3Health News:Crest(R) SPINBRUSH(R) Oral Hygiene Survey Reveals "Nothin' but the Tooth" 4Health News:Restaurant inspections -- public perceptions vs. reality 2Health News:New Treatment Offers Hope for Beating Aggressive Cancers 2
Basic modular VICTOR2 Multilabel Counter (3 technologies)
Manual VICTOR2 with fluorescence, fluorescence polarization and luminescence technologies
VICTOR2 V (5 technologies) with stackers and robotic loading
VICTOR2 multilabel counter with IR, high density TR-fluorometry, stacker and robot loading
Medicine Products: